
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 10, 2023, titled "Zydus and Torrent sign licensing agreement for co-marketing Saroglitazar Mg, a critical treatment for chronic liver diseases in India".
Filed with NSE ·

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 10, 2023, titled "Zydus and Torrent sign licensing agreement for co-marketing Saroglitazar Mg, a critical treatment for chronic liver diseases in India".
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences